Figure 2.

Immunoblot pattern produced by a serum sample from a liver kidney microsomal type 1 (LKM1) negative chronic hepatitis C virus (HCV) infected patient with anti-formimino-transferase cyclodeaminase (FTCD) antibodies on electrophoretically separated human liver homogenate (lane 1). The 58–60 kDa immunofixed band almost completely abolished when the reactive serum was pre-incubated with recombinant FTCD as solid phase competitor (lane 2).